Status:
TERMINATED
Intranasal Ketamine Versus Intramuscular Ketamine for Procedural Sedation in Pediatric Patients
Lead Sponsor:
University of Iowa
Conditions:
Sedation
Eligibility:
All Genders
2-17 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if intranasal ketamine is equally as effective and safe as intramuscular ketamine for procedural sedation in pediatric patients.
Eligibility Criteria
Inclusion
- pediatric patients age 2 to 17 years old
- have a laceration of 4 cm on the face or 7 cm on the remainder of the body
- Require procedural sedation to repair the laceration
Exclusion
- Patients with abnormal nasal physiology which would not allow for adequate medication delivery
- Unable to have a guardian present to consent on their behalf
- Allergy to ketamine
- Significant cardiac history (myocardial ischemia, heart failure, arrhythmias)
- Presenting with a head injury associated with possible intracranial hypertension
- Pregnancy
- Lacerations that require repair from a consult service
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT01170247
Start Date
January 1 2011
End Date
January 1 2012
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States, 52242